Maseru – Lesotho and the United States have entered a new health partnership following the signing of a five year bilateral cooperation agreement that will channel more than M6.21 billion into the country’s health system. The signing took place on 10 December and was attended by senior government officials and representatives of the US Embassy.
The agreement was signed by Lesotho’s Minister of Finance Dr Retšelisitsoe Matlanyane and the United States Embassy Chargé d’Affaires Thomas Hines. The two countries committed to a combined investment of USD 364 million to support the country’s long term health priorities. The United States intends to contribute USD 232 million while the Government of Lesotho plans to invest USD 132 million.
According to officials, the funding will support efforts to expand HIV and AIDS programmes, improve the health workforce, enhance disease surveillance and strengthen health data systems. The programme aims to help Lesotho build a more self sustaining national health system over the next five years. 
The partnership builds on years of cooperation between the two countries which has contributed to notable progress against HIV and AIDS. Lesotho has exceeded global treatment targets with a 97 97 99 performance and continues to introduce new prevention tools. During the signing ceremony, Health Minister Selibe Mochoboroane confirmed that the country will soon roll out Lenacapavir, a long acting HIV prevention medication that government expects will help reduce new infections.
The Minister of Finance described the new funding partnership as timely given the health challenges facing many Basotho. She expressed appreciation for the continued support from the United States and noted that the collaboration places Lesotho in a stronger position to safeguard earlier gains made in the health sector.
